Dear Pharmaceutical Management Agency,

I am requesting information about the funding of Ixekizumab (brand name Taltz).

Specifically, I would like to know if:

a) This medication is currently being considered for funding, has been considered for funding in the past, or if there is any indication it will be considered in the near future?

b) If the medication is being considered for funding, I would like to know which autoimmune conditions it is being considered as a treatment option for.

Yours faithfully,
Ms Faulkner